Skip to main content

Table 4 Co-expression levels of PPAT and CAD with proteasome genes in 11 types of cancer

From: Systematic analyses of glutamine and glutamate metabolisms across different cancer types

Cancer Gene
PPAT CAD
PSMD1 PSMD11 PSMD14 PSME3 PSME4 PSMB5 PSMD1 PSMD2 PSME3 PSME4
BLCA 0.26 0.37 0.37 0.38 0.23 0.26 0.33 0.48 0.29 0.24
BRCA 0.36 0.42 0.32 0.37 0.29    0.33   0.35
COAD   0.27 0.38 0.33      0.29 0.36
HNSC   0.33 0.24 0.36 0.33     0.29 0.37
KICH 0.36 0.33 0.25 0.43 0.47 0.27     
KIRC 0.26 0.38    0.29    0.22   0.37
KIRP 0.44 0.49 0.47 0.28 0.35   0.28 0.24   0.24
LIHC 0.24 0.27 0.25 0.45      0.43  
LUAD 0.33 0.48 0.46 0.47 0.42   0.3 0.36 0.32 0.47
PRAD   0.35   0.43 0.36    0.29 0.34 0.26
THCA   0.48   0.42 0.25    0.4   
  1. PPAT, phosphoribosyl pyrophosphate amidotransferase; CAD, carbamoyl-Phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; PSMD1, proteasome 26S subunit, non-ATPase 1; PSMD11, proteasome 26S subunit, non-ATPase 11; PSMD14, proteasome 26S subunit, non-ATPase 14; PSME3, proteasome activator subunit 3; PSME4, proteasome activator subunit 4; PSMB5, proteasome subunit beta 5; PSMD2, proteasome 26S subunit, non-ATPase 2
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us